{"id":15299,"date":"2012-09-04T08:30:00","date_gmt":"2012-09-04T06:30:00","guid":{"rendered":"http:\/\/www.fedaiisf.it\/federaisf-firenze-spending-review-%c2%96-prescrizione\/"},"modified":"2012-09-04T08:30:00","modified_gmt":"2012-09-04T06:30:00","slug":"federaisf-firenze-spending-review-%c2%96-prescrizione","status":"publish","type":"post","link":"https:\/\/www.fedaiisf.it\/en\/federaisf-firenze-spending-review-%c2%96-prescrizione\/","title":{"rendered":"FEDERAISF FLORENCE. Spending Review \u2013 Prescription"},"content":{"rendered":"<p class=\"MsoNormal\" style=\"text-align: left; margin: 0cm 0cm 10pt\"><font size=\"3\"><font face=\"Calibri\">Dear colleagues,<\/p>\n<p><\/font><\/font><\/p>\n<p class=\"MsoNormal\" style=\"text-align: left; margin: 0cm 0cm 10pt\"><font size=\"3\"><font face=\"Calibri\">We send you the two significant documents regarding the new prescription methods introduced with the decree concerning the ossiap spending review.<\/p>\n<p><\/font><\/font><\/p>\n<p class=\"MsoNormal\" style=\"text-align: left; margin: 0cm 0cm 10pt\"><font size=\"3\"><font face=\"Calibri\">1) <u>law published in the official gazette<\/u>.<\/p>\n<p><\/font><\/font><\/p>\n<p class=\"MsoNormal\" style=\"text-align: left; margin: 0cm 0cm 10pt\"><font size=\"3\"><font face=\"Calibri\">2) <u>explanatory note published on the AIFA website<\/u><\/p>\n<p><\/font><\/font><\/p>\n<p class=\"MsoNormal\" style=\"text-align: left; margin: 0cm 0cm 10pt\"><font size=\"3\"><font face=\"Calibri\">We suggest everyone to print them for the interview with the doctors in case there are doubts or simplistic positions that have emerged in these days on several levels<\/p>\n<p><\/font><\/font><\/p>\n<p class=\"MsoNormal\" align=\"center\" style=\"text-align: center; margin: 0cm 0cm 10pt\"><b style=\"mso-bidi-font-weight: normal\"><font size=\"3\"><font face=\"Calibri\">IMPORTANT POINTS to highlight:<\/p>\n<p><\/font><\/font><\/b><\/p>\n<p class=\"MsoNormal\" style=\"text-align: left; margin: 0cm 0cm 10pt\"><b style=\"mso-bidi-font-weight: normal\"><span style=\"color: #c00000\"><font size=\"3\"><font face=\"Calibri\">THE LAW IS NOT ABOUT<\/p>\n<p><\/font><\/font><\/span><\/b><\/p>\n<p class=\"MsoNormal\" style=\"text-align: left; margin: 0cm 0cm 10pt\"><font size=\"3\"><font face=\"Calibri\">1) drugs covered by patent<\/p>\n<p><\/font><\/font><\/p>\n<p class=\"MsoNormal\" style=\"text-align: left; margin: 0cm 0cm 10pt\"><font size=\"3\"><font face=\"Calibri\">2) class C<\/p>\n<p><\/font><\/font><\/p>\n<p class=\"MsoNormal\" style=\"text-align: left; margin: 0cm 0cm 10pt\"><font size=\"3\"><font face=\"Calibri\">3) white recipe<\/p>\n<p><\/font><\/font><\/p>\n<p class=\"MsoNormal\" style=\"text-align: left; margin: 0cm 0cm 10pt\"><font size=\"3\"><font face=\"Calibri\">In all these cases the Brand can be prescribed without any problem<\/p>\n<p><\/font><\/font><\/p>\n<p class=\"MsoNormal\" style=\"text-align: left; margin: 0cm 0cm 10pt\"><b style=\"mso-bidi-font-weight: normal\"><span style=\"color: #c00000\"><font size=\"3\"><font face=\"Calibri\">Drug prescription GENERATED on prescription SNN:<\/p>\n<p><\/font><\/font><\/span><\/b><\/p>\n<p class=\"MsoNormal\" style=\"text-align: left; margin: 0cm 0cm 10pt\"><font size=\"3\"><font face=\"Calibri\">1) CONTINUING CHRONIC THERAPY the BRAND can continue to be prescribed without any problems<\/p>\n<p><\/font><\/font><\/p>\n<p class=\"MsoNormal\" style=\"text-align: left; margin: 0cm 0cm 10pt\"><font size=\"3\"><font face=\"Calibri\"><span style=\"mso-spacerun: yes\">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <\/span>&#8212;&#8212;&#8212;&#8212;&#8212;&#8211;<\/p>\n<p><\/font><\/font><\/p>\n<p class=\"MsoNormal\" style=\"text-align: left; margin: 0cm 0cm 10pt\"><font size=\"3\"><font face=\"Calibri\">2) FIRST treatment NEW CHRONIC patient o <\/p>\n<p><\/font><\/font><\/p>\n<p class=\"MsoNormal\" style=\"text-align: left; margin: 0cm 0cm 10pt\"><font size=\"3\"><font face=\"Calibri\">3) FIRST treatment of NEW NON-chronic episode<\/p>\n<p><\/font><\/font><\/p>\n<p class=\"MsoNormal\" style=\"text-align: left; margin: 0cm 0cm 10pt\"><font size=\"3\"><font face=\"Calibri\">In these two cases the doctor has 3 CHOICES:<\/p>\n<p><\/font><\/font><\/p>\n<p class=\"MsoNormal\" style=\"text-align: left; margin: 0cm 0cm 10pt\"><font size=\"3\"><font face=\"Calibri\">1) ACTIVE PRINCIPLE +BRAND<\/p>\n<p><\/font><\/font><\/p>\n<p class=\"MsoNormal\" style=\"text-align: left; margin: 0cm 0cm 10pt\"><font size=\"3\"><font face=\"Calibri\">2) ACTIVE INGREDIENT + BRAND + NOT REPLACEABLE + SYNTHETIC MOTIVATION<\/p>\n<p><\/font\n<\/p>","protected":false},"excerpt":{"rendered":"<p>Cari Colleghi, Vi inviamo in allegato i due documenti significativi riguardo le nuove modalit&agrave; di prescrizione introdotte con il decreto inerente la spending review ossiap 1) legge pubblicata in gazzetta ufficiale. 2) nota esplicativa pubblicata sul sito dell AIFA Suggeriamo a tutti di stamparli per il colloquio con i medici nei casi ci fossero dubbio &hellip;<\/p>","protected":false},"author":1,"featured_media":9846,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[90],"tags":[],"class_list":["post-15299","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-fedaiisf-archivio-storico"],"amp_enabled":true,"_links":{"self":[{"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/posts\/15299","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/comments?post=15299"}],"version-history":[{"count":0,"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/posts\/15299\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/media\/9846"}],"wp:attachment":[{"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/media?parent=15299"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/categories?post=15299"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/tags?post=15299"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}